Reports
-
Foreign Assistance to Combat HIV/AIDS, Tuberculosis, and Malaria Fiscal Year 2021 Inspectors General Coordinated PEPFAR Oversight Plan U.S. Department of Health and Human Services, Office of Inspector General
-
Texas Relied on Impermissible Provider-Related Donations To Fund the State Share of the Medicaid Delivery System Reform Incentive Payment Program
-
Medicare Contractors Were Not Consistent in How They Reviewed Extrapolated Overpayments in the Provider Appeals Process
-
CMS Encounter Data Lack Essential Information That Medicare Advantage Organizations Have the Ability to Collect
-
Indiana Properly Reported Adjustments Related to the Drug Rebate Program
-
Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2018 Average Sales Prices.
-
Medicare Home Health Agency Provider Compliance Audit: Mission Home Health of San Diego, Inc.
-
Opioid Use in Medicare Part D Continued To Decline in 2019, but Vigilance Is Needed as COVID-19 Raises New Concerns
-
Retrieving data. Wait for a few seconds, then try cutting or copying again.
-
Medicare Laboratory Test Expenditures Increased in 2018, Despite New Rate Reductions
-
Medicare Home Health Agency Provider Compliance Audit: Condado Home Care Program, Inc.
-
Visionquest Industries, Inc.: Audit of Medicare Payments for Orthotic Braces
-
Desoto Home Health Care, Inc.: Audit of Medicare Payments for Orthotic Braces
-
Inadequate Edits and Oversight Caused Medicare To Overpay More Than $267 Million for Hospital Inpatient Claims With Post-Acute-Care Transfers to Home Health Services
-
North Carolina Did Not Ensure That Nursing Facilities Always Reported Allegations of Potential Abuse and Neglect of Medicaid Beneficiaries and Did Not Always Prioritize Allegations Timely
-
The New York State Medicaid Agency Made Capitation Payments to Managed Care Organizations After Beneficiaries Deaths
-
On-Site Psychological Services, P.C.: Audit of Medicare Payments for Psychotherapy Services
-
Alaska Claimed Unallowable Federal Reimbursement for Some Medicaid Physician-Administered Drugs
-
CMS Could Have Saved $192 Million by Targeting Home Health Claims for Review With Visits Slightly Above the Threshold That Triggers a Higher Medicare Payment
-
Advisory Opinion 20-04